Li Chengwei, He Zhimin, Lv Fajin, Liu Yang, Hu Yan, Zhang Jian, Liu Hui, Ma Si, Xiao Zhibo
State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Insights Imaging. 2023 Jul 19;14(1):129. doi: 10.1186/s13244-023-01445-2.
Accurate preoperative assessment of the efficacy of high-intensity focused ultrasound (HIFU) ablation for uterine fibroids is essential for good treatment results. The aim of this study was to develop robust radiomics models for predicting the prognosis of HIFU-treated uterine fibroids and to explain the internal predictive process of the model using Shapley additive explanations (SHAP).
This retrospective study included 300 patients with uterine fibroids who received HIFU and were classified as having a favorable or unfavorable prognosis based on the postoperative nonperfusion volume ratio. Patients were divided into a training set (N = 240) and a test set (N = 60). The 1295 radiomics features were extracted from T2-weighted imaging (T2WI) and contrast-enhanced T1-weighted imaging (CE-T1WI) scans. After data preprocessing and feature filtering, radiomics models were constructed by extreme gradient boosting and light gradient boosting machine (LightGBM), and the optimal performance was obtained by Bayesian optimization. Finally, the SHAP approach was used to explain the internal prediction process.
The models constructed using LightGBM had the best performance, and the AUCs of the T2WI and CE-T1WI models were 87.2 (95% CI = 87.1-87.5) and 84.8 (95% CI = 84.6-85.7), respectively. The use of SHAP technology can help physicians understand the impact of radiomic features on the predicted outcomes of the model from a global and individual perspective.
Multiparametric radiomic models have shown their robustness in predicting HIFU prognosis. Radiomic features can be a potential source of biomarkers to support preoperative assessment of HIFU treatment and improve the understanding of uterine fibroid heterogeneity.
An interpretable radiomics model can help clinicians to effectively predict the prognosis of HIFU treatment for uterine fibroids. The heterogeneity of fibroids can be characterized by various radiomics features and the application of SHAP can be used to visually explain the prediction process of radiomics models.
准确的术前评估高强度聚焦超声(HIFU)消融子宫肌瘤的疗效对于良好的治疗效果至关重要。本研究的目的是建立强大的放射组学模型来预测HIFU治疗子宫肌瘤的预后,并使用Shapley加性解释(SHAP)来解释模型的内部预测过程。
这项回顾性研究纳入了300例接受HIFU治疗的子宫肌瘤患者,并根据术后无灌注体积比分为预后良好或不良组。患者分为训练集(N = 240)和测试集(N = 60)。从T2加权成像(T2WI)和对比增强T1加权成像(CE-T1WI)扫描中提取1295个放射组学特征。经过数据预处理和特征筛选后,通过极端梯度提升和轻量级梯度提升机(LightGBM)构建放射组学模型,并通过贝叶斯优化获得最佳性能。最后,使用SHAP方法解释内部预测过程。
使用LightGBM构建的模型性能最佳,T2WI模型和CE-T1WI模型的AUC分别为87.2(95%CI = 87.1-87.5)和84.8(95%CI = 84.6-85.7)。使用SHAP技术可以帮助医生从全局和个体角度理解放射组学特征对模型预测结果的影响。
多参数放射组学模型在预测HIFU预后方面显示出其稳健性。放射组学特征可能是生物标志物的潜在来源,以支持HIFU治疗的术前评估并增进对子宫肌瘤异质性的理解。
一个可解释的放射组学模型可以帮助临床医生有效预测HIFU治疗子宫肌瘤的预后。肌瘤的异质性可以通过各种放射组学特征来表征,并且SHAP的应用可用于直观地解释放射组学模型的预测过程。